Schonfeld Strategic Advisors »

Vistagen Therapeutics Ord shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Vistagen Therapeutics Ord (VTGN) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Vistagen Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Vistagen Therapeutics Ord held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vistagen Therapeutics Ord by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $39k 11k 3.55
2023-09-30 $726k 139k 5.24

More positions owned by Schonfeld Strategic Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Ethereum Tr SHS (ETHA)
Fidelity Wise Origin Bitcoin SHS (FBTC)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ark 21shares Bitcoin Etf Shs Ben Int (ARKB)
Broadcom (AVGO)
Ishares Tr Core S&p500 Etf (IVV)
Alibaba Group Hldg Sponsored Ads (BABA)
Union Pacific Corporation (UNP)
Tesla Motors (TSLA)
Marvell Technology (MRVL)
Boston Scientific Corporation (BSX)

View all positions for Schonfeld Strategic Advisors

Top funds holding Vistagen Therapeutics Ord

Henderson Group
OrbiMed Advisors
TCG Crossover Management
Stempoint Capital
Nantahala Capital Management
Vanguard Group
Commodore Capital
Ikarian Capital
Soleus Capital Management
Citadel Advisors
Diadema Partners
BlackRock
Renaissance Technologies
Susquehanna International
Jane Street

View all funds holding Vistagen Therapeutics Ord